Oxidized galectin-1 is an essential factor for peripheral nerve regeneration. 2005

Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
Advanced Research Center for Biological Science, Waseda University, Waseda University Higashifushimi Campus, Nishitokyo City, Tokyo, Japan. horie-hidenori@waseda.jp

Although many factors have been implicated in the regenerative response of peripheral axons to nerve injury, the signals that prompt neurons to extend processes in peripheral nerves after axotomy are not well-understood. As shown in the first chapter, oxidized recombinant human galectin-1 (rhGAL-1/Ox), which lacks lectin activity, promotes initial axonal growth in an in vitro peripheral nerve regeneration model at low concentrations (pg/ml). At a similarly low concentration, rhGAL-1/Ox has also been shown to be effective in enhancing axonal regeneration using in vivo experiments. Moreover, the application of functional anti-rhGAL-1 antibody strongly inhibited axonal regeneration in vivo as well as in vitro. Since galectin-1 (GAL-1) is expressed in the regenerating sciatic nerves as well as in both sensory and motoneurons, these results indicate that GAL-1, which is secreted into the extracellular space, is subsequently oxidized and then may regulate initial repair after axotomy. This possibility was confirmed by Western blot analysis, which revealed that both reduced and oxidized forms of GAL-1 are present in culture media of DRG neurons and immortalized adult mouse Schwann cells (IMS32). Externalized GAL-1/Ox has been found to stimulate macrophages to secrete an axonal regeneration-promoting factor. From these results, we propose that axonal regeneration occurs in axotomized peripheral nerves as a result of cytosolic reduced GAL-1 being released from Schwann cells and injured axons, which then becomes oxidized in the extracellular space. GAL-1/Ox in the extracellular space stimulates macrophages to secrete a factor that promotes axonal growth and Schwann cell migration, thus enhancing peripheral nerve regeneration and functional recovery. These results suggest that rhGAL-1/Ox may be a novel factor for functional restoration of injured peripheral nerves.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009416 Nerve Regeneration Renewal or physiological repair of damaged nerve tissue. Nerve Tissue Regeneration,Nervous Tissue Regeneration,Neural Tissue Regeneration,Nerve Tissue Regenerations,Nervous Tissue Regenerations,Neural Tissue Regenerations,Regeneration, Nerve,Regeneration, Nerve Tissue,Regeneration, Nervous Tissue,Regeneration, Neural Tissue,Tissue Regeneration, Nerve,Tissue Regeneration, Nervous,Tissue Regeneration, Neural
D010525 Peripheral Nerves The nerves outside of the brain and spinal cord, including the autonomic, cranial, and spinal nerves. Peripheral nerves contain non-neuronal cells and connective tissue as well as axons. The connective tissue layers include, from the outside to the inside, the epineurium, the perineurium, and the endoneurium. Endoneurium,Epineurium,Perineurium,Endoneuriums,Epineuriums,Nerve, Peripheral,Nerves, Peripheral,Perineuriums,Peripheral Nerve
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001369 Axons Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body. Axon
D012583 Schwann Cells Neuroglial cells of the peripheral nervous system which form the insulating myelin sheaths of peripheral axons. Schwann Cell,Cell, Schwann,Cells, Schwann
D014182 Transplantation, Autologous Transplantation of an individual's own tissue from one site to another site. Autografting,Autologous Transplantation,Autotransplantation,Autograftings,Autologous Transplantations,Autotransplantations,Transplantations, Autologous
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D020426 Sciatic Neuropathy Disease or damage involving the SCIATIC NERVE, which divides into the PERONEAL NERVE and TIBIAL NERVE (see also PERONEAL NEUROPATHIES and TIBIAL NEUROPATHY). Clinical manifestations may include SCIATICA or pain localized to the hip, PARESIS or PARALYSIS of posterior thigh muscles and muscles innervated by the peroneal and tibial nerves, and sensory loss involving the lateral and posterior thigh, posterior and lateral leg, and sole of the foot. The sciatic nerve may be affected by trauma; ISCHEMIA; COLLAGEN DISEASES; and other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1363) Sciatic Nerve Diseases,Lesion of Sciatic Nerve,Neuralgia-Neuritis, Sciatic Nerve,Sciatic Nerve Palsy,Sciatic Neuritis,Nerve Disease, Sciatic,Nerve Diseases, Sciatic,Nerve Lesion, Sciatic,Nerve Lesions, Sciatic,Nerve Palsies, Sciatic,Nerve Palsy, Sciatic,Neuralgia Neuritis, Sciatic Nerve,Neuralgia-Neuritides, Sciatic Nerve,Neuritides, Sciatic,Neuritis, Sciatic,Neuropathies, Sciatic,Neuropathy, Sciatic,Palsies, Sciatic Nerve,Palsy, Sciatic Nerve,Sciatic Nerve Disease,Sciatic Nerve Lesion,Sciatic Nerve Lesions,Sciatic Nerve Neuralgia-Neuritides,Sciatic Nerve Neuralgia-Neuritis,Sciatic Nerve Palsies,Sciatic Neuritides,Sciatic Neuropathies

Related Publications

Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
September 2003, Cellular and molecular biology (Noisy-le-Grand, France),
Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
May 2016, Oncotarget,
Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
January 2018, Scientific reports,
Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
August 2016, Development (Cambridge, England),
Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
January 2018, Biomedical research (Tokyo, Japan),
Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
May 2004, Journal of reconstructive microsurgery,
Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
January 2011, Neurorehabilitation and neural repair,
Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
December 2010, Plastic and reconstructive surgery,
Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
September 2006, Science (New York, N.Y.),
Hidenori Horie, and Toshihiko Kadoya, and Kazunori Sango, and Mitsuhiro Hasegawa
May 2009, Experimental neurology,
Copied contents to your clipboard!